Anti-ADDL antibodies and uses thereof

Details for Australian Patent Application No. 2011204912 (hide)

International Classifications

Event Publications

11 August 2011 Complete Application Filed

18 August 2011 Application Open to Public Inspection

Published as AU-B-2011204912

1 September 2011 Alteration of Name

The name of the applicant has been altered to Northwestern University; Merck Sharp & Dohme Corp.

10 May 2012 Application Accepted

Published as AU-B-2011204912

7 June 2012 Application for Amendment

The nature of the amendment is: Amend the name of the inventor to read Acton, Paul; An, Zhiqiang; Bett, Andrew J.; Breese, Robert; Dodson, Elizabeth Chen; Kinney, Gene; Liang, Xiaoping; Shughrue, Paul; Strohl, William R.. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Melbourne VIC 3000

27 September 2012 Amendment Made

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.